DexCom: Revenue Up, EPS Misses Mark

DexCom: Revenue Up, EPS Misses Mark

Source: 
Motley Fool
snippet: 
  • Revenue for Q4 2024 was $1.114 billion, marking an 8% increase year-over-year.
  • Non-GAAP EPS stood at $0.45, missing the estimated $0.50 and reflecting a 10% decline from Q4 2023.
  • Operating income (non-GAAP) decreased to $209.5 million from $242.7 million.